Your prediction
Pros and Cons of Amp Ltd. in the next few years
Pros
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Amp Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Amp Ltd. | 1.980% | 0.000% | 0.000% | 7.853% | 0.000% | 21.893% | 1.980% |
| Commonwealth Bank Australia | -0.870% | -4.509% | -0.170% | -6.401% | -4.187% | 29.942% | 60.570% |
| National Australia Bank | 2.410% | -0.899% | 2.514% | 6.497% | 2.169% | 25.647% | 62.688% |
| Australia and New Zealand Banking Group Ltd. | 1.640% | -1.143% | 2.393% | 16.366% | 1.121% | 33.233% | 35.282% |
News
Elicio (ELTX) Q2 Loss Beats Estimates
Elicio Therapeutics (NASDAQ:ELTX), a biotechnology company focused on immunotherapies for cancer, reported its second quarter results on August 7, 2025, for the period ending June 30. The company
